{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-046279","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2023-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.147840+00:00","generated_at":"2026-06-07T07:05:28.593718+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Biofrontera elects Hoffman & Weber as directors, ratifies Marcum as auditor","bullets":["Elected Beth J. Hoffman (531,471 for) and Kevin D. Weber (531,796 for) as Class II directors for terms ending 2026.","Ratified Marcum LLP as independent auditor for FY 2023 (878,777 for, 2,734 against, 2,256 abstain).","Annual Meeting quorum: 883,767 shares (58.2% of 1,517,628 outstanding) present on Dec 20, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-046279","json":"https://secwatch.observer/filing/0001493152-23-046279.json","markdown":"https://secwatch.observer/filing/0001493152-23-046279.md","text":"https://secwatch.observer/filing/0001493152-23-046279.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046279/0001493152-23-046279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046279/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T07:05:28.593718+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"581c58f9e04cafca8933d41b72c463e89e6190d5","claim":"Biofrontera Inc. shareholders approved Ratification of Appointment of Independent Public Accounting Firm (Marcum LLP) at the 2023-12-20 meeting.","evidence_excerpt":"Ratification of Appointment of Independent Public Accounting Firm For Against Abstain Broker Non-Votes 878,777 2,734 2,256 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046279/0001493152-23-046279-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-20"}],"fact_type":"shareholder_vote"},{"claim_id":"c847b919cfa284abcabcc8a3aca4b181794671e8","claim":"Biofrontera Inc. shareholders approved Election of Beth J. Hoffman, Ph.D. and Kevin D. Weber as Class II Directors at the 2023-12-20 meeting.","evidence_excerpt":"Beth J. Hoffman, Ph.D. For Withheld Broker Non-Votes 531,471 9,810 342,486","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1858685/000149315223046279/0001493152-23-046279-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-20"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}